Tomudex 2 mg (Raltitrexed (Raltitrexed) POWDER FOR SOLUTION) 2 MG

Tomudex 2 mg is a powder for solution used in intravenous therapy. This medication, containing raltitrexed, is manufactured by Pfizer Canada ULC and is commonly associated with certain cancer treatments.

Strength

2 MG

Pack Size

5ML VIAL

Manufacturer / TM Owner

PFIZER CANADA ULC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Tomudex 2 mg is primarily used in the management of specific types of cancer. Raltitrexed, the active ingredient, is often utilized in chemotherapy regimens. Patients and healthcare providers may explore its uses for advanced or metastatic cancer, though specific applications should be discussed with a medical professional.

Side Effects

Common effects of Tomudex 2 mg may include fatigue, nausea, and changes in blood cell counts. Some individuals might experience gastrointestinal discomfort or hair loss. These effects can vary widely among patients, and it is important to monitor for any unusual symptoms.

Precautions & Warnings

Tomudex 2 mg should be handled with care, as it is a potent medication. It is essential to follow proper storage and administration guidelines to ensure safety. Patients should be aware of potential side effects and discuss any concerns with their healthcare provider.

Avoid Interactions

Tomudex 2 mg may interact with other medications, particularly those that affect the immune system or blood cell production. Alcohol and certain supplements might also influence its effectiveness. Patients should inform their healthcare provider about all medications they are taking to avoid potential interactions.

Frequently Asked Questions

Tomudex 2 mg is used in the management of certain types of cancer, often as part of a chemotherapy regimen.

Tomudex 2 mg is administered intravenously as a powder for solution.

Common side effects may include fatigue, nausea, and changes in blood cell counts.

Tomudex 2 mg may interact with other medications, so it is important to consult a healthcare provider before combining it with other treatments.

Tomudex 2 mg is manufactured by Pfizer Canada ULC.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.